Suppresses osteosarcoma cell growth and invasion by affecting the PI3K/AKT pathway; Enhances the sensitivity of osteosarcoma cells to Cisplatin through the GAS5/miR-26b-5p/TP53INP1 axis. The gene discussed is TP53INP1; the disease is osteosarcoma.